Inventor
GOVINDAN SERENGULAM V
US108 patents
⚠️ This page may combine multiple inventors who share the name “GOVINDAN SERENGULAM V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOMEDICS INC
40 patentsUS7999083B2Aug 16, 2011
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC184 citations99
US7591994B2Sep 22, 2009
Camptothecin-binding moiety conjugates
IMMUNOMEDICS INC129 citations99
US7585491B2Sep 8, 2009
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC148 citations99
US9492566B2Nov 15, 2016
Antibody-drug conjugates and uses thereof
IMMUNOMEDICS INC61 citations98
US9138485B2Sep 22, 2015
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC32 citations98
US9028833B2May 12, 2015
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC48 citations98
US8759496B2Jun 24, 2014
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC38 citations98
US9198978B2Dec 1, 2015
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC20 citations96
US9102735B2Aug 11, 2015
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC27 citations96
US8999344B2Apr 7, 2015
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC19 citations96
US6558669B1May 6, 2003
Stable radioiodine conjugates and methods for their synthesis
IMMUNOMEDICS INC35 citations96
US6120768ASep 19, 2000
Dota-biotin derivatives
IMMUNOMEDICS INC68 citations96
US10682347B2Jun 16, 2020
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC11 citations94
US10137196B2Nov 27, 2018
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC18 citations94
US10130626B2Nov 20, 2018
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC18 citations94
US10265414B2Apr 23, 2019
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC6 citations93
US10130718B2Nov 20, 2018
Antibody-drug conjugates and uses thereof
IMMUNOMEDICS INC12 citations93
US10064957B2Sep 4, 2018
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC14 citations93
US9675706B2Jun 13, 2017
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC6 citations93
US9629926B2Apr 25, 2017
Antibody-SN-38 immunoconjugates with a CL2A linker
IMMUNOMEDICS INC21 citations93
US9522959B2Dec 20, 2016
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC13 citations93
US9493573B2Nov 15, 2016
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC12 citations93
US9493574B2Nov 15, 2016
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC7 citations93
US9480756B2Nov 1, 2016
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC13 citations93
US9388237B2Jul 12, 2016
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC12 citations93
US9345783B2May 24, 2016
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC12 citations93
US9238084B2Jan 19, 2016
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
IMMUNOMEDICS INC36 citations93
US9233172B2Jan 12, 2016
Immunoconjugates with an intracellularly-cleavable linkage
IMMUNOMEDICS INC12 citations93
US9226973B2Jan 5, 2016
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
IMMUNOMEDICS INC7 citations93
US8834886B2Sep 16, 2014
Camptothecin-binding moiety conjugates
IMMUNOMEDICS INC18 citations93
US8758752B2Jun 24, 2014
RS7 antibodies
IMMUNOMEDICS INC16 citations93
US7147856B2Dec 12, 2006
Stable radioiodine conjugates and methods of their synthesis
IMMUNOMEDICS INC13 citations93
US5846741ADec 8, 1998
Boron neutron capture therapy using pre-targeting methods
IMMUNOMEDICS INC31 citations93
US9694088B2Jul 4, 2017
Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
IMMUNOMEDICS INC11 citations92
US9375489B2Jun 28, 2016
Antibody-SN-38 immunoconjugates with a CL2A linker
IMMUNOMEDICS INC21 citations92
US9107960B2Aug 18, 2015
Antibody-SN-38 immunoconjugates with a CL2A linker
IMMUNOMEDICS INC16 citations92
US8877202B2Nov 4, 2014
Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
IMMUNOMEDICS INC27 citations92
US5965131AOct 12, 1999
Delivery of diagnostic and therapeutic agents to a target site
IMMUNOMEDICS INC30 citations92
US5958408ASep 28, 1999
Delivery of diagnostic and therapeutic agents to a target site
IMMUNOMEDICS INC44 citations92
US7230085B2Jun 12, 2007
Anti-DOTA antibody
IMMUNOMEDICS INC25 citations90
GOVINDAN SERENGULAM V
10 patentsUS8425912B2Apr 23, 2013
Immunoconjugates with an intracellularly-cleavable linkage
GOVINDAN SERENGULAM V82 citations99
US8268319B2Sep 18, 2012
Immunoconjugates with an intracellularly-cleavable linkage
GOVINDAN SERENGULAM V79 citations99
US8080250B1Dec 20, 2011
Immunoconjugates with an intracellularly-cleavable linkage
GOVINDAN SERENGULAM V106 citations99
US8420086B2Apr 16, 2013
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
GOVINDAN SERENGULAM V68 citations98
US8268317B2Sep 18, 2012
Camptothecin-binding moiety conjugates
GOVINDAN SERENGULAM V82 citations98
US8084583B2Dec 27, 2011
RS7 antibodies
GOVINDAN SERENGULAM V44 citations98
US8741300B2Jun 3, 2014
Immunoconjugates with an intracellularly-cleavable linkage
GOVINDAN SERENGULAM V25 citations96
US8877901B2Nov 4, 2014
Camptothecin-binding moiety conjugates
GOVINDAN SERENGULAM V50 citations94
US8574575B2Nov 5, 2013
RS7 antibodies
GOVINDAN SERENGULAM V13 citations93
US8435529B2May 7, 2013
Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
GOVINDAN SERENGULAM V30 citations93
Showing the top 50 of 108 patents by PatentIndex Score.